| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 10/10/2002 | WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 10/10/2002 | WO2002080160A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer |
| 10/10/2002 | WO2002080159A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer |
| 10/10/2002 | WO2002080152A2 Optical data carrier that contains a heterocyclic azo dye as the light-absorbing compound in the information layer |
| 10/10/2002 | WO2002080150A2 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness |
| 10/10/2002 | WO2002079198A1 Pyridazinone aldose reductase inhibitors |
| 10/10/2002 | WO2002079190A1 3-substituted indoles as chemokine antagonists |
| 10/10/2002 | WO2002079186A2 Aminopiperidine derivatives as modulators of chemokine receptor activity |
| 10/10/2002 | WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 10/10/2002 | WO2002078744A1 Remedies for psychoneurosis |
| 10/10/2002 | WO2002078628A2 Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazapines as hiv reverse transcriptase inhibitors |
| 10/10/2002 | US20020147341 Kinase inhibitor; benign prostatic hyperplasia |
| 10/10/2002 | US20020147224 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases |
| 10/10/2002 | US20020147207 Azabicyclic spiroether derivatives and their use as therapeutic agents |
| 10/10/2002 | US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents |
| 10/10/2002 | US20020147188 Protease inhibitors |
| 10/10/2002 | DE10117464A1 Optical data medium for information recording, has cover layer and adhesive layer having preset total thickness, and recorded and readout with focussing objective lens setup having preset numerical aperture |
| 10/10/2002 | CA2442476A1 Pyridazinone aldose reductase inhibitors |
| 10/10/2002 | CA2441778A1 Aminopiperidine derivatives as modulators of chemokine receptor activity |
| 10/10/2002 | CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 10/09/2002 | EP1247809A2 Triazine compounds useful as sorbitol dehydrogenase inhibitors |
| 10/09/2002 | EP1247452A2 Fungicidal combinations of active agents |
| 10/09/2002 | EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/09/2002 | EP1246625A2 Methods and compositions for mitigating pain using nitrate esters |
| 10/09/2002 | EP0996622B1 Novel spiroazabicyclic heterocyclic compounds |
| 10/09/2002 | EP0946542B1 Indane or dihydroindole derivatives |
| 10/09/2002 | CN1373131A Process and apparatus for extracting and separating high-purity monomolecular camptothecine |
| 10/09/2002 | CN1373130A Process for preparing indolizine |
| 10/09/2002 | CN1092188C Substd. aminoquinazolinone (thione) derivs. or salts thereof, intermediates thereof, and pest controller and method for using same |
| 10/08/2002 | US6462196 Preparation of a camptothecin derivative by intramolecular cyclization |
| 10/08/2002 | US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases |
| 10/08/2002 | US6462056 Oxazolidines as 5-HT2A-antagonists |
| 10/08/2002 | US6462053 Neuropeptide y receptor antagonists; cardiovascular and central nervous system disorders and metabolic diseases; hypertension, nephropathy, heart disease, vasospasm, arteriosclerosis |
| 10/08/2002 | US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism |
| 10/08/2002 | CA2220995C New derivatives of substituted 7,12-dioxa-benzo¬a|anthracenes, their preparation process and the pharmaceutical compositions they contain |
| 10/06/2002 | WO2003088897A2 Fab i inhibitors |
| 10/06/2002 | CA2444597A1 Fab i inhibitors |
| 10/03/2002 | WO2002077984A1 Optical data carrier containing a xanthene dye in the information layer thereof as a light-absorbing compound |
| 10/03/2002 | WO2002076989A1 Protein phosphate inhibitors |
| 10/03/2002 | WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 10/03/2002 | WO2002076973A1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 10/03/2002 | WO2002076954A1 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases |
| 10/03/2002 | WO2002076448A1 Molecular conjugates for use in treatment of cancer |
| 10/03/2002 | WO2002076404A2 Fatty alcohol drug conjugates |
| 10/03/2002 | WO2002076402A2 Fatty amine drug conjugates |
| 10/03/2002 | WO2002076375A2 Process for the preparation of benazepril |
| 10/03/2002 | WO2002012188A3 Indole compounds useful for the treatment of cancer |
| 10/03/2002 | WO2001076603A1 Medicinal compositions containing camptothecin derivative and ph regulating agent |
| 10/03/2002 | WO2000034265A3 Quinoline-indole antimicrobial agents |
| 10/03/2002 | US20020143017 Pyridazinone aldose reductase inhibitors |
| 10/03/2002 | US20020142968 For therapeutic and/or prophylactic treatment of idiopathic and adult respiratory distress syndrome, pulmonary fibrosis following treatment with radiation or chemotherapy, septic shock, septicemia, inflammatory responses |
| 10/03/2002 | CA2442573A1 Process for the preparation of benazepril |
| 10/03/2002 | CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 10/03/2002 | CA2441484A1 Molecular conjugates for use in treatment of cancer |
| 10/03/2002 | CA2441377A1 Protein phosphate inhibitors |
| 10/03/2002 | CA2405453A1 Pharmaceutical composition containing camptothecin derivative and ph-adjusting substance |
| 10/02/2002 | EP1245565A1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 10/02/2002 | EP1245229A2 Methods and compositions for inhibition of angiogenesis |
| 10/02/2002 | EP1244652A1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 10/02/2002 | DE10106969C1 Verfahren zur Reinigung und zur Herstellung von 20(S)-Camptothecin Process for cleaning and for the production of 20 (S) -camptothecin |
| 10/02/2002 | CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 10/01/2002 | US6458965 Herbicides, antigrowth agents and surfactants for wood preservatives |
| 10/01/2002 | US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes |
| 10/01/2002 | US6458830 The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis and postherpetic neuralgia. |
| 10/01/2002 | US6458825 Eukaryotic cells contain multiple proteolytic systems, including lysosomal proteases, calpains, atp-ubiquitin-proteasome dependent pathway, and an |
| 10/01/2002 | US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases |
| 10/01/2002 | US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458802 Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f]quinoline |
| 10/01/2002 | US6458798 Bicyclic pyrimidine compounds and therapeutic use thereof |
| 10/01/2002 | US6458792 Medicament for the treatment of inflammatory, immunological, bronchopulmonary, cardiovascular, oncological or cns-degenerative disorders. |
| 10/01/2002 | US6458784 Vitronectin receptor antagonists |
| 10/01/2002 | US6458474 Methine compound, material for organic luminescence element, organic luminescence element using the same |
| 09/30/2002 | CA2379791A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors |
| 09/26/2002 | WO2002074776A2 Highly purified and crystalline form of harringtonine |
| 09/26/2002 | WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 09/26/2002 | WO2002074746A1 Benzazepine derivatives |
| 09/26/2002 | WO2002074738A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 09/26/2002 | WO2002032872A8 Nitrogenous aromatic ring compounds |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | US20020137950 Disodium(2S,3S)-tetrahydro-3-hydroxy-5-oxo-2,3-furandicarboxylate for example, as well as corresponding acyl halides, esters, cyclic imides, and protected hydroxyl derivates thereof |
| 09/26/2002 | US20020137762 Delivery systems and methods for noscapine and noscapine derivatives, useful as anticancer agents |
| 09/26/2002 | US20020137755 Tyrosine kinase inhibitors |
| 09/26/2002 | US20020137744 Metalloprotease inhibitors |
| 09/26/2002 | US20020137225 Useful as agent for measurement of nitrogen monoxide, also for measuring intracellular nitrogen monoxide concentration of an individual |
| 09/26/2002 | CA2441428A1 Highly purified and crystalline form of harringtonine |
| 09/26/2002 | CA2439539A1 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 09/25/2002 | EP1243268A1 Medicinal composition |
| 09/25/2002 | EP1242426A1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 09/25/2002 | EP1242422A1 Tricyclic dihydropyrimidine potassium channel openers |
| 09/25/2002 | EP1242382A1 Tricyclic protein kinase inhibitors |
| 09/25/2002 | EP1242082A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 09/25/2002 | EP1242080A1 Dopamine transporter inhibitors and their use |
| 09/25/2002 | EP1181279A4 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 09/25/2002 | EP0931081B1 Pyridazino 4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists |
| 09/25/2002 | EP0923570B1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives |
| 09/25/2002 | EP0906314B1 Optical resolution of narwedine-type compounds |
| 09/25/2002 | EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 09/25/2002 | EP0835257B1 Intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds |
| 09/25/2002 | EP0746556B1 Tricyclic compounds having affinity for the 5-ht1a receptor |